Mary Farone investigates microbial genomics, host–pathogen interactions, and antimicrobial discovery. She integrates RNA-seq, CRISPR, and medicinal chemistry to profile OMV‑mediated signaling and bacterial/fungal virulence, advancing leads against resistant pathogens in environmental and clinical settings.